Sector Chart MBX Biosciences, Inc.

Equities

MBX

US55287L1017

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-17 pm EDT			5-day change	1st Jan Change
33.77 ^USD	+1.66%		+8.94%	+7.07%

Mar. 16	Mbx Biosciences Insider Bought Shares Worth $525,663, According to a Recent SEC Filing	MT
Mar. 12	MBX Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales growth	Profitability	Finances	EV / Sales	P/E
MBX BIOSCIENCES, INC.	1.6B	-	-	-	-	-
LONZA GROUP AG	48.69B
BEONE MEDICINES AG	35.92B
REVOLUTION MEDICINES, INC.	31.26B	-	-	-	-	-
CELLTRION, INC.	29.77B
IQVIA HOLDINGS INC.	29.62B